Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In

TipRanks2022-03-28

Competition for top dog billing in the Covid-19 vaccine space has basically turned into a two-horse race. So far, Pfizer (PFE)/BioNTech (BNTX)lead the way, but Moderna (MRNA)has provided the stiffest ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • ZZX86
    2022-03-29
    ZZX86
    Awesomeeee！😆
  • Tigon
    2022-03-28
    Tigon
    🙂
  • GggSlimeR
    2022-03-28
    GggSlimeR
    Let's buy Do not like my comment 
  • mster
    2022-03-28
    mster
    As many countries have started opening up and easing regulations even for those non-vaccinated, I guess these vaccines companies may have already reach a plateau? 
  • bobbylim
    2022-03-28
    bobbylim
    Nice
  • Taishu1234
    2022-03-28
    Taishu1234
    hi
Leave a comment
14